The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Female Contraceptives-Global Market Insights and Sales Trends 2024
Synopsis
The global Female Contraceptives market size is expected to reach US$ 22120 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Female Contraceptives in various end use industries. The expanding demands from the Personal use and Hospital, are propelling Female Contraceptives market. Contraceptive Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Contraceptive Devices segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Female Contraceptives market, driven by demand from China, the second largest economy with some signs of stabilising, the Female Contraceptives market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Female Contraceptives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Female Contraceptives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Female Contraceptives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Female Contraceptives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Female Contraceptives covered in this report include Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, Merck, Johnson & Johnson, Lupin Pharmaceuticals and Female Health Company, etc.
The global Female Contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex
Global Female Contraceptives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Female Contraceptives market, Segment by Type:
Contraceptive Drugs
Contraceptive Devices
Global Female Contraceptives market, by Application
Personal use
Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Female Contraceptives companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Female Contraceptives market size is expected to reach US$ 22120 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Female Contraceptives in various end use industries. The expanding demands from the Personal use and Hospital, are propelling Female Contraceptives market. Contraceptive Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Contraceptive Devices segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Female Contraceptives market, driven by demand from China, the second largest economy with some signs of stabilising, the Female Contraceptives market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Female Contraceptives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Female Contraceptives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Female Contraceptives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Female Contraceptives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Female Contraceptives covered in this report include Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, Merck, Johnson & Johnson, Lupin Pharmaceuticals and Female Health Company, etc.
The global Female Contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex
Global Female Contraceptives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Female Contraceptives market, Segment by Type:
Contraceptive Drugs
Contraceptive Devices
Global Female Contraceptives market, by Application
Personal use
Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Female Contraceptives companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Female Contraceptives
1.1 Female Contraceptives Market Overview
1.1.1 Female Contraceptives Product Scope
1.1.2 Female Contraceptives Market Status and Outlook
1.2 Global Female Contraceptives Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Female Contraceptives Market Size by Region (2018-2029)
1.4 Global Female Contraceptives Historic Market Size by Region (2018-2023)
1.5 Global Female Contraceptives Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Female Contraceptives Market Size (2018-2029)
1.6.1 North America Female Contraceptives Market Size (2018-2029)
1.6.2 Europe Female Contraceptives Market Size (2018-2029)
1.6.3 Asia-Pacific Female Contraceptives Market Size (2018-2029)
1.6.4 Latin America Female Contraceptives Market Size (2018-2029)
1.6.5 Middle East & Africa Female Contraceptives Market Size (2018-2029)
2 Female Contraceptives Market by Type
2.1 Introduction
2.1.1 Contraceptive Drugs
2.1.2 Contraceptive Devices
2.2 Global Female Contraceptives Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Female Contraceptives Historic Market Size by Type (2018-2023)
2.2.2 Global Female Contraceptives Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Female Contraceptives Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Female Contraceptives Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Female Contraceptives Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Female Contraceptives Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Female Contraceptives Revenue Breakdown by Type (2018-2029)
3 Female Contraceptives Market Overview by Application
3.1 Introduction
3.1.1 Personal use
3.1.2 Hospital
3.2 Global Female Contraceptives Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Female Contraceptives Historic Market Size by Application (2018-2023)
3.2.2 Global Female Contraceptives Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Female Contraceptives Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Female Contraceptives Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Female Contraceptives Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Female Contraceptives Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Female Contraceptives Revenue Breakdown by Application (2018-2029)
4 Female Contraceptives Competition Analysis by Players
4.1 Global Female Contraceptives Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraceptives as of 2022)
4.3 Date of Key Players Enter into Female Contraceptives Market
4.4 Global Top Players Female Contraceptives Headquarters and Area Served
4.5 Key Players Female Contraceptives Product Solution and Service
4.6 Competitive Status
4.6.1 Female Contraceptives Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Female Contraceptives Products, Services and Solutions
5.1.4 Bayer Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 Mayer Laboratories
5.2.1 Mayer Laboratories Profile
5.2.2 Mayer Laboratories Main Business
5.2.3 Mayer Laboratories Female Contraceptives Products, Services and Solutions
5.2.4 Mayer Laboratories Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.2.5 Mayer Laboratories Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Female Contraceptives Products, Services and Solutions
5.3.4 Pfizer Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.3.5 Mylan Recent Developments
5.4 Mylan
5.4.1 Mylan Profile
5.4.2 Mylan Main Business
5.4.3 Mylan Female Contraceptives Products, Services and Solutions
5.4.4 Mylan Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.4.5 Mylan Recent Developments
5.5 Teva
5.5.1 Teva Profile
5.5.2 Teva Main Business
5.5.3 Teva Female Contraceptives Products, Services and Solutions
5.5.4 Teva Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.5.5 Teva Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Female Contraceptives Products, Services and Solutions
5.6.4 Merck Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Female Contraceptives Products, Services and Solutions
5.7.4 Johnson & Johnson Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson Recent Developments
5.8 Lupin Pharmaceuticals
5.8.1 Lupin Pharmaceuticals Profile
5.8.2 Lupin Pharmaceuticals Main Business
5.8.3 Lupin Pharmaceuticals Female Contraceptives Products, Services and Solutions
5.8.4 Lupin Pharmaceuticals Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.8.5 Lupin Pharmaceuticals Recent Developments
5.9 Female Health Company
5.9.1 Female Health Company Profile
5.9.2 Female Health Company Main Business
5.9.3 Female Health Company Female Contraceptives Products, Services and Solutions
5.9.4 Female Health Company Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.9.5 Female Health Company Recent Developments
5.10 Fuji Latex
5.10.1 Fuji Latex Profile
5.10.2 Fuji Latex Main Business
5.10.3 Fuji Latex Female Contraceptives Products, Services and Solutions
5.10.4 Fuji Latex Female Contraceptives Revenue (US$ Million) & (2018-2023)
5.10.5 Fuji Latex Recent Developments
6 North America
6.1 North America Female Contraceptives Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Female Contraceptives Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Female Contraceptives Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Female Contraceptives Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Female Contraceptives Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Female Contraceptives Market Dynamics
11.1 Female Contraceptives Industry Trends
11.2 Female Contraceptives Market Drivers
11.3 Female Contraceptives Market Challenges
11.4 Female Contraceptives Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
